GridAI Technologies GRDX
NASDAQ GRDX
$2.95 -0.07 (-2.16%)
As of: Sep 10, 2026 · 3:09 PM EDT

GridAI Technologies (GRDX) Common Equity (2015 - 2026)

GridAI Technologies' (GRDX) quarterly Common Equity came in at $14.9 million in Q2 2026, up 336.23% on a YoY basis from $3.4 million in Q2 2025, and down 40.35% quarter-over-quarter from $24.9 million in Q4 2025.

Analysis

GridAI Technologies (GRDX) Common Equity (2015 - 2026) Analysis & Trends

GridAI Technologies (GRDX) has reported Common Equity for 12 consecutive years, with $14.9 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Common Equity rose 336.23% year-over-year to $14.9 million; the trailing twelve-month figure through Jun 2026 stood at $14.9 million (up 336.23% YoY), and the FY2025 full-year result was $24.9 million, up 743.4% from the prior year.
  • Common Equity fell to $14.9 million in Q2 2026 per GRDX's latest filing, from $24.9 million in the prior quarter.
  • Across five years, Common Equity topped out at $50.0 million in Q3 2022 and bottomed at -$14.2 million in Q2 2022.
  • Historically, Common Equity has averaged $7.4 million across 5 years, with a median of $3.3 million in 2023.
  • The sharpest annual moves came in 2022 and 2024: Common Equity tumbled 301.65% in 2022, then soared 934.13% in 2024.
  • Over 5 years, Common Equity stood at $2.7 million in 2022, then jumped by 31.39% to $3.6 million in 2023, then tumbled by 207.6% to -$3.9 million in 2024, then jumped by 743.4% to $24.9 million in 2025, then slumped by 40.35% to $14.9 million in 2026.
  • According to Business Quant data, Common Equity over the past three periods registered $14.9 million, $24.9 million, and $27.9 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Amgen 206.74 Bn 192.75 Bn 7.24 Bn 11.69 Bn
2 Gilead Sciences 179.96 Bn 176.78 Bn 6.22 Bn 11.83 Bn
3 Vertex Pharmaceuticals 131.20 Bn 123.35 Bn 2.84 Bn 20.25 Bn
4 Regeneron Pharmaceuticals 82.05 Bn 74.05 Bn 3.93 Bn 31.71 Bn
5 Argenx Se 60.28 Bn 55.10 Bn 1.37 Bn 8.42 Bn
6 Moderna 53.67 Bn 48.54 Bn 52.00 Mn 6.76 Bn
7 Alnylam Pharmaceuticals 33.08 Bn 29.78 Bn 992.69 Mn 1.35 Bn
8 Biogen 31.91 Bn 30.62 Bn 1.96 Bn 18.85 Bn
9 Roivant Sciences 29.22 Bn 29.22 Bn 1.16 Mn 4.92 Bn
10 GridAI Technologies 18.97 Mn 18.97 Mn -36,514.00 14.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.88 Mn
Dec 31, 2025 24.94 Mn
Sep 30, 2025 27.88 Mn
Jun 30, 2025 -6.30 Mn
Mar 31, 2025 -5.22 Mn
Dec 31, 2024 -3.88 Mn
Sep 30, 2024 8.37 Mn
Jun 30, 2024 9.12 Mn
Mar 31, 2024 16.18 Mn
Dec 31, 2023 3.60 Mn
Sep 30, 2023 3.28 Mn
Jun 30, 2023 881,960.00
Mar 31, 2023 2.71 Mn
Dec 31, 2022 2.74 Mn
Sep 30, 2022 50.00 Mn
Jun 30, 2022 -14.19 Mn
Mar 31, 2022 -9.24 Mn
Dec 31, 2021 -7.82 Mn
Sep 30, 2021 -6.97 Mn
Jun 30, 2021 7.04 Mn